TY - JOUR
T1 - Immunoreactivity of S100 beta in heart, skeletal muscle, and kidney in chronic lung disease
T2 - possible induction by cAMP.
AU - Kahn, H. J.
AU - Baumal, R.
AU - Van Eldik, L. J.
AU - Dunn, R. J.
AU - Marks, A.
PY - 1991/11
Y1 - 1991/11
N2 - S100 protein is a calcium-binding protein composed of two subunits S100 alpha and S100 beta, which are expressed selectively by specific cell types. The distribution of S100 beta was examined among various tissues obtained at autopsy from 18 subjects with chronic lung disease and 10 control subjects. The presence of S100 beta in individual cell types was demonstrated by immunoperoxidase staining using polyclonal and monoclonal antibodies specific for S100 beta. In the 10 control subjects, positive staining was seen in a number of cell types that normally produce S100 alpha and S100 beta, (e.g., glial cells, melanocytes, chondrocytes) or only S100 beta, (e.g., Schwann cells). There was no staining of myocardial cells, skeletal muscle fibers, or kidney tubules, which normally produce S100 alpha but not S100 beta. In contrast, in the 18 subjects with chronic lung disease, all of the above cell types stained positively for S100 beta, showing that in these subjects cell types that ordinarily expressed only S100 alpha also expressed S100 beta. We suggest that the observed induction of S100 beta in these cell types seen in subjects with chronic lung disease was mediated by an elevation of cAMP levels secondary to bronchodilator therapy with beta-adrenergic agonists and phosphodiesterase inhibitors.
AB - S100 protein is a calcium-binding protein composed of two subunits S100 alpha and S100 beta, which are expressed selectively by specific cell types. The distribution of S100 beta was examined among various tissues obtained at autopsy from 18 subjects with chronic lung disease and 10 control subjects. The presence of S100 beta in individual cell types was demonstrated by immunoperoxidase staining using polyclonal and monoclonal antibodies specific for S100 beta. In the 10 control subjects, positive staining was seen in a number of cell types that normally produce S100 alpha and S100 beta, (e.g., glial cells, melanocytes, chondrocytes) or only S100 beta, (e.g., Schwann cells). There was no staining of myocardial cells, skeletal muscle fibers, or kidney tubules, which normally produce S100 alpha but not S100 beta. In contrast, in the 18 subjects with chronic lung disease, all of the above cell types stained positively for S100 beta, showing that in these subjects cell types that ordinarily expressed only S100 alpha also expressed S100 beta. We suggest that the observed induction of S100 beta in these cell types seen in subjects with chronic lung disease was mediated by an elevation of cAMP levels secondary to bronchodilator therapy with beta-adrenergic agonists and phosphodiesterase inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=0026251645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026251645&partnerID=8YFLogxK
M3 - Article
C2 - 1664955
AN - SCOPUS:0026251645
SN - 0893-3952
VL - 4
SP - 698
EP - 701
JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
JF - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
IS - 6
ER -